The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Radioembolization Therapy-Global Market Insights and Sales Trends 2025
Synopsis
The global Radioembolization Therapy market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Radioembolization Therapy in various end use industries. The expanding demands from the Hospital, Clinics, Ambulatory Surgical Centers and Other, are propelling Radioembolization Therapy market. Transarterial Radioembolization (TARE), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Selective Internal Radiation Therapy (SIRT) segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Radioembolization Therapy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Radioembolization Therapy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Radioembolization Therapy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Radioembolization Therapy sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Radioembolization Therapy covered in this report include Terumo Corporation, Merit Medical Systems Inc., Cook Medical, Boston Scientific Corporation, Medtronic plc, Stryker Corporation, Depuy Synthes (J&J) and BTG International Limited, etc.
The global Radioembolization Therapy market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Terumo Corporation
Merit Medical Systems Inc.
Cook Medical
Boston Scientific Corporation
Medtronic plc
Stryker Corporation
Depuy Synthes (J&J)
BTG International Limited
Global Radioembolization Therapy market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Radioembolization Therapy market, Segment by Type:
Transarterial Radioembolization (TARE)
Selective Internal Radiation Therapy (SIRT)
Global Radioembolization Therapy market, by Application
Hospital
Clinics
Ambulatory Surgical Centers
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Radioembolization Therapy companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Radioembolization Therapy market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Radioembolization Therapy in various end use industries. The expanding demands from the Hospital, Clinics, Ambulatory Surgical Centers and Other, are propelling Radioembolization Therapy market. Transarterial Radioembolization (TARE), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Selective Internal Radiation Therapy (SIRT) segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Radioembolization Therapy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Radioembolization Therapy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Radioembolization Therapy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Radioembolization Therapy sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Radioembolization Therapy covered in this report include Terumo Corporation, Merit Medical Systems Inc., Cook Medical, Boston Scientific Corporation, Medtronic plc, Stryker Corporation, Depuy Synthes (J&J) and BTG International Limited, etc.
The global Radioembolization Therapy market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Terumo Corporation
Merit Medical Systems Inc.
Cook Medical
Boston Scientific Corporation
Medtronic plc
Stryker Corporation
Depuy Synthes (J&J)
BTG International Limited
Global Radioembolization Therapy market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Radioembolization Therapy market, Segment by Type:
Transarterial Radioembolization (TARE)
Selective Internal Radiation Therapy (SIRT)
Global Radioembolization Therapy market, by Application
Hospital
Clinics
Ambulatory Surgical Centers
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Radioembolization Therapy companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Radioembolization Therapy
1.1 Radioembolization Therapy Market Overview
1.1.1 Radioembolization Therapy Product Scope
1.1.2 Radioembolization Therapy Market Status and Outlook
1.2 Global Radioembolization Therapy Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Radioembolization Therapy Market Size by Region (2018-2029)
1.4 Global Radioembolization Therapy Historic Market Size by Region (2018-2023)
1.5 Global Radioembolization Therapy Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Radioembolization Therapy Market Size (2018-2029)
1.6.1 North America Radioembolization Therapy Market Size (2018-2029)
1.6.2 Europe Radioembolization Therapy Market Size (2018-2029)
1.6.3 Asia-Pacific Radioembolization Therapy Market Size (2018-2029)
1.6.4 Latin America Radioembolization Therapy Market Size (2018-2029)
1.6.5 Middle East & Africa Radioembolization Therapy Market Size (2018-2029)
2 Radioembolization Therapy Market by Type
2.1 Introduction
2.1.1 Transarterial Radioembolization (TARE)
2.1.2 Selective Internal Radiation Therapy (SIRT)
2.2 Global Radioembolization Therapy Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Radioembolization Therapy Historic Market Size by Type (2018-2023)
2.2.2 Global Radioembolization Therapy Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Radioembolization Therapy Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Radioembolization Therapy Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Radioembolization Therapy Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Radioembolization Therapy Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Radioembolization Therapy Revenue Breakdown by Type (2018-2029)
3 Radioembolization Therapy Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Clinics
3.1.3 Ambulatory Surgical Centers
3.1.4 Other
3.2 Global Radioembolization Therapy Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Radioembolization Therapy Historic Market Size by Application (2018-2023)
3.2.2 Global Radioembolization Therapy Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Radioembolization Therapy Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Radioembolization Therapy Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Radioembolization Therapy Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Radioembolization Therapy Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Radioembolization Therapy Revenue Breakdown by Application (2018-2029)
4 Radioembolization Therapy Competition Analysis by Players
4.1 Global Radioembolization Therapy Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Radioembolization Therapy as of 2022)
4.3 Date of Key Players Enter into Radioembolization Therapy Market
4.4 Global Top Players Radioembolization Therapy Headquarters and Area Served
4.5 Key Players Radioembolization Therapy Product Solution and Service
4.6 Competitive Status
4.6.1 Radioembolization Therapy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Terumo Corporation
5.1.1 Terumo Corporation Profile
5.1.2 Terumo Corporation Main Business
5.1.3 Terumo Corporation Radioembolization Therapy Products, Services and Solutions
5.1.4 Terumo Corporation Radioembolization Therapy Revenue (US$ Million) & (2018-2023)
5.1.5 Terumo Corporation Recent Developments
5.2 Merit Medical Systems Inc.
5.2.1 Merit Medical Systems Inc. Profile
5.2.2 Merit Medical Systems Inc. Main Business
5.2.3 Merit Medical Systems Inc. Radioembolization Therapy Products, Services and Solutions
5.2.4 Merit Medical Systems Inc. Radioembolization Therapy Revenue (US$ Million) & (2018-2023)
5.2.5 Merit Medical Systems Inc. Recent Developments
5.3 Cook Medical
5.3.1 Cook Medical Profile
5.3.2 Cook Medical Main Business
5.3.3 Cook Medical Radioembolization Therapy Products, Services and Solutions
5.3.4 Cook Medical Radioembolization Therapy Revenue (US$ Million) & (2018-2023)
5.3.5 Boston Scientific Corporation Recent Developments
5.4 Boston Scientific Corporation
5.4.1 Boston Scientific Corporation Profile
5.4.2 Boston Scientific Corporation Main Business
5.4.3 Boston Scientific Corporation Radioembolization Therapy Products, Services and Solutions
5.4.4 Boston Scientific Corporation Radioembolization Therapy Revenue (US$ Million) & (2018-2023)
5.4.5 Boston Scientific Corporation Recent Developments
5.5 Medtronic plc
5.5.1 Medtronic plc Profile
5.5.2 Medtronic plc Main Business
5.5.3 Medtronic plc Radioembolization Therapy Products, Services and Solutions
5.5.4 Medtronic plc Radioembolization Therapy Revenue (US$ Million) & (2018-2023)
5.5.5 Medtronic plc Recent Developments
5.6 Stryker Corporation
5.6.1 Stryker Corporation Profile
5.6.2 Stryker Corporation Main Business
5.6.3 Stryker Corporation Radioembolization Therapy Products, Services and Solutions
5.6.4 Stryker Corporation Radioembolization Therapy Revenue (US$ Million) & (2018-2023)
5.6.5 Stryker Corporation Recent Developments
5.7 Depuy Synthes (J&J)
5.7.1 Depuy Synthes (J&J) Profile
5.7.2 Depuy Synthes (J&J) Main Business
5.7.3 Depuy Synthes (J&J) Radioembolization Therapy Products, Services and Solutions
5.7.4 Depuy Synthes (J&J) Radioembolization Therapy Revenue (US$ Million) & (2018-2023)
5.7.5 Depuy Synthes (J&J) Recent Developments
5.8 BTG International Limited
5.8.1 BTG International Limited Profile
5.8.2 BTG International Limited Main Business
5.8.3 BTG International Limited Radioembolization Therapy Products, Services and Solutions
5.8.4 BTG International Limited Radioembolization Therapy Revenue (US$ Million) & (2018-2023)
5.8.5 BTG International Limited Recent Developments
6 North America
6.1 North America Radioembolization Therapy Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Radioembolization Therapy Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Radioembolization Therapy Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Radioembolization Therapy Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Radioembolization Therapy Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Radioembolization Therapy Market Dynamics
11.1 Radioembolization Therapy Industry Trends
11.2 Radioembolization Therapy Market Drivers
11.3 Radioembolization Therapy Market Challenges
11.4 Radioembolization Therapy Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
